Trial
NCT00936767
Artemisone for the Treatment of Uncomplicated Falciparum Malaria in Western Cambodia
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Oxford
Collaborators
Mahidol University; Medicines for Malaria Venture
Condition
Uncomplicated Falciparum Malaria
Intervention
Artemisone/Mefloquine (AmiM3)
Why stopped
Did not get approval
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-08-31